As adiponectin and leptin exert antagonistic effects on liver fibrogenesis and inflammation, the ratio of adiponectin to leptin may be a better marker for distinguishing NASH from NAFLD. Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.